Armata Pharmaceuticals, Inc. (ARMP) Revenue (2016 - 2018)
Armata Pharmaceuticals' Revenue history spans 6 years, with the latest figure at -$337000.0 for Q4 2018.
- For Q4 2018, Revenue fell 1785.0% year-over-year to -$337000.0; the TTM value through Dec 2018 reached -$644000.0, down 660.0%, while the annual FY2024 figure was -$5.6 million, 392.59% down from the prior year.
- Revenue for Q4 2018 was -$337000.0 at Armata Pharmaceuticals, down from -$307000.0 in the prior quarter.
- Across five years, Revenue topped out at $143000.0 in Q3 2015 and bottomed at -$337000.0 in Q4 2018.
- The 5-year median for Revenue is $101000.0 (2014), against an average of $28647.1.
- The largest annual shift saw Revenue surged 3533.33% in 2014 before it tumbled 1785.0% in 2018.
- A 5-year view of Revenue shows it stood at $101000.0 in 2014, then soared by 41.58% to $143000.0 in 2015, then crashed by 84.62% to $22000.0 in 2016, then fell by 9.09% to $20000.0 in 2017, then crashed by 1785.0% to -$337000.0 in 2018.
- Per Business Quant, the three most recent readings for ARMP's Revenue are -$337000.0 (Q4 2018), -$307000.0 (Q3 2018), and $20000.0 (Q4 2017).